Tag: merger
-
AI Drug Discovery Company Acquired in $270M Deal
A biotechnology company using protein dynamics to develop precision cancer therapies is acquiring a drug discovery company based on machine learning algorithms.
-
Molecular Diagnostics Company Acquired in $1.8B Deal
GenMark Diagnostics, a developer of diagnostics systems using genomic analysis, was acquired by drug maker Roche in a deal valued at $1.8 billion.
-
Gene-Editing Biotech Acquires DNA Bar Code Company
A developer of therapies using highly precise gene editing is acquiring a company delivering gene therapies identified with DNA bar codes.
-
Cannabidiol Drug Maker Acquired in $7.2B Deal
A developer of treatments for rare neurological diseases derived from cannabis is being acquired by Jazz Pharmaceuticals in a $7.2 billion deal.
-
2020 Venture Funds Mixed, Biotech Keeps Sizzling
Total venture investments in dollars jumped to a new high in the U.S., while biotechnology remained the single hottest sector in 2020.
-
Neuroscience Biotech Acquired in $770M Deal
A three year-old biotechnology company developing treatments for psychiatric and movement disorders is being acquired by global drug maker Novartis.
-
Oral Drug Delivery Company Acquired in $1.8B Deal
Emisphere Technologies, developers of a process that makes biologic drugs available as oral medicines is being acquired by drug maker Novo Nordisk.
-
Venture Rounds, IPOs, Mergers Vanish in Election Week
Nationwide jitters in the U.S. appear to be affecting venture capital activities in the week of the presidential and congressional elections.
-
Bayer Gains Gene Therapy Biotech in $4B Deal
Global drug maker Bayer AG is acquiring the company Asklepios BioPharmaceutical, developer of gene therapies to treat inherited disorders.
-
Lilly Gains Neuro Disease Biotech in $1.36B Deal
Drug maker Eli Lilly and Co. is acquiring Disarm Therapeutics, a biotechnology company developing treatments for neurodegenerative disorders.